Retatrutide
Also known as: LY3437943 · GGG tri-agonist
An investigational triple-hormone-receptor agonist studied in metabolic and body-weight research.
View in catalog →Overview
Retatrutide is an investigational peptide that engages three incretin/metabolic receptors at once — GIP, GLP-1, and glucagon. It is among the most closely watched compounds in current metabolic clinical research, following the earlier GLP-1 and dual GIP/GLP-1 classes.
How it’s studied to work
By simultaneously activating GIP, GLP-1, and glucagon receptors, it is studied for combined effects on insulin secretion, appetite signalling, and energy expenditure that single- or dual-agonists do not cover.
Research areas
- ›Metabolic and glucose-regulation research
- ›Body-weight and energy-balance studies
- ›Multi-receptor incretin pharmacology
Handling & storage
- Storage
- Lyophilized; store cold, long-term at −20 °C.
- Reconstitution
- Bacteriostatic water for laboratory reconstitution.
Further reading
Links open external literature databases. Citations are curated starting points, not an exhaustive or endorsing list.
For laboratory and research use only. Not a drug, supplement, or medical device. This page is educational and is not medical advice; nothing here describes a product intended for human or veterinary use.